Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT05890352

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Led by SWOG Cancer Research Network ยท Updated on 2025-10-20

227

Participants Needed

104

Research Sites

274 weeks

Total Duration

On this page

Sponsors

S

SWOG Cancer Research Network

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This phase 2 trial studies the side effects and best dose of tazemetostat and zanubrutinib in combination with tafasitamab and lenalidomide, and to see how well these combinations work in treating patients with large B-cell lymphoma that returned or did not respond to earlier treatment. Tazemetostat is in a class of medications called EZH2 inhibitors. It helps to stop the spread of cancer cells. Zanubrutinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells. tafasitamab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Lenalidomide is in a class of medications called immunomodulatory agents. It works by helping the bone marrow to produce normal blood cells and by killing abnormal cells in the bone marrow. The addition of tazemetostat or zanubrutinib to tafasitamab and lenalidomide may be able to shrink the cancer or extend the time without cancer symptoms coming back.

CONDITIONS

Official Title

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years or older
  • Histologically confirmed relapsed or refractory large B-cell lymphoma or related types including grade 3B follicular lymphoma, transformed lymphoma, and high grade B-cell lymphoma with or without MYC, BCL2 and/or BCL6 rearrangements
  • Cell of origin determination of germinal center B-cell subtype based on pathology report
  • 1 to 5 prior systemic treatment regimens including at least one multiagent regimen for aggressive lymphoma
  • Completed prior systemic therapy and recovered from previous treatment effects
  • Steroid use for lymphoma symptoms allowed but must be stopped before first treatment cycle
  • Zubrod Performance Status of 0 to 3
  • Complete medical history and physical exam within 28 days before registration
  • Absolute neutrophil count of at least 1.0 x 10^3/uL (or 0.75 x 10^3/uL if bone marrow involved) within 28 days before registration
  • Platelet count of at least 75 x 10^3/uL (or 50 x 10^3/uL if bone marrow involved) within 28 days before registration
  • AST and ALT levels at or below 3 times the institutional upper limit of normal, or up to 5 times if liver involved
  • Total bilirubin at or below 1.5 times institutional upper limit of normal, or up to 5 times if liver involved
  • Calculated creatinine clearance of at least 30 mL/min within 28 days before registration
  • Clinical cardiac risk assessment of class 2B or better if history of cardiac disease
  • Recovered from adverse events of prior anti-cancer therapy except alopecia
  • For HIV positive participants, on effective anti-retroviral therapy with undetectable viral load within 6 months
  • For hepatitis B infection, undetectable viral load with suppressive therapy
  • For hepatitis C infection, undetectable viral load within 28 days before registration
  • Able to swallow and retain oral medication without significant gastrointestinal issues
  • Agree to participate in specimen banking
  • Able to complete FACT-Lym and PRO-CTCAE forms in English or Spanish
  • Provide informed consent according to guidelines
Not Eligible

You will not qualify if you...

  • Active lymphoma involvement of the central nervous system
  • Known abnormalities linked to myelodysplastic syndrome or myeloproliferative neoplasms
  • History of T-cell lymphoblastic lymphoma or T-cell acute leukemia
  • Candidate for or declined autologous stem cell transplant, except those with disease progression after stem cell transplant or cellular therapy
  • Prior treatment with tafasitamab and/or lenalidomide
  • Prior treatment with BTK inhibitors or tazemetostat
  • Known allergy or reaction to study drugs (tafasitamab, lenalidomide, tazemetostat, zanubrutinib)
  • Currently taking direct vitamin K inhibitors or strong/moderate CYP3A inhibitors or inducers
  • Prior or concurrent malignancy that may interfere with safety or efficacy assessments
  • Pregnant or nursing; must follow lenalidomide Risk Evaluation and Mitigation Strategies including use of effective contraception if of reproductive potential

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 104 locations

1

Banner University Medical Center - Tucson

Tucson, Arizona, United States, 85719

Actively Recruiting

2

University of Arizona Cancer Center-North Campus

Tucson, Arizona, United States, 85719

Actively Recruiting

3

Tower Cancer Research Foundation

Beverly Hills, California, United States, 90211

Actively Recruiting

4

City of Hope Comprehensive Cancer Center

Duarte, California, United States, 91010

Actively Recruiting

5

City of Hope Seacliff

Huntington Beach, California, United States, 92648

Actively Recruiting

6

City of Hope Antelope Valley

Lancaster, California, United States, 93534

Actively Recruiting

7

City of Hope at Long Beach Elm

Long Beach, California, United States, 90813

Actively Recruiting

8

Cedars Sinai Medical Center

Los Angeles, California, United States, 90048

Actively Recruiting

9

City of Hope Newport Beach

Newport Beach, California, United States, 92660

Actively Recruiting

10

City of Hope South Pasadena

South Pasadena, California, United States, 91030

Actively Recruiting

11

City of Hope South Bay

Torrance, California, United States, 90503

Actively Recruiting

12

City of Hope Upland

Upland, California, United States, 91786

Actively Recruiting

13

Holy Cross Hospital

Fort Lauderdale, Florida, United States, 33308

Actively Recruiting

14

Mount Sinai Medical Center

Miami Beach, Florida, United States, 33140

Suspended

15

University of Illinois

Chicago, Illinois, United States, 60612

Actively Recruiting

16

University of Chicago Comprehensive Cancer Center

Chicago, Illinois, United States, 60637

Actively Recruiting

17

Carle at The Riverfront

Danville, Illinois, United States, 61832

Actively Recruiting

18

Carle Physician Group-Effingham

Effingham, Illinois, United States, 62401

Actively Recruiting

19

Carle Physician Group-Mattoon/Charleston

Mattoon, Illinois, United States, 61938

Actively Recruiting

20

UC Comprehensive Cancer Center at Silver Cross

New Lenox, Illinois, United States, 60451

Actively Recruiting

21

University of Chicago Medicine-Orland Park

Orland Park, Illinois, United States, 60462

Actively Recruiting

22

Memorial Hospital East

Shiloh, Illinois, United States, 62269

Actively Recruiting

23

Carle Cancer Center

Urbana, Illinois, United States, 61801

Actively Recruiting

24

Northwest Cancer Center - Main Campus

Crown Point, Indiana, United States, 46307

Actively Recruiting

25

Northwest Oncology LLC

Dyer, Indiana, United States, 46311

Actively Recruiting

26

Northwest Cancer Center - Hobart

Hobart, Indiana, United States, 46342

Actively Recruiting

27

Saint Mary Medical Center

Hobart, Indiana, United States, 46342

Actively Recruiting

28

Saint Catherine Hospital

Indianapolis, Indiana, United States, 46312

Actively Recruiting

29

The Community Hospital

Munster, Indiana, United States, 46321

Actively Recruiting

30

Women's Diagnostic Center - Munster

Munster, Indiana, United States, 46321

Actively Recruiting

31

Northwest Cancer Center - Valparaiso

Valparaiso, Indiana, United States, 46383

Actively Recruiting

32

UI Health Care Mission Cancer and Blood - Ankeny Clinic

Ankeny, Iowa, United States, 50023

Suspended

33

Mercy Hospital

Cedar Rapids, Iowa, United States, 52403

Actively Recruiting

34

Oncology Associates at Mercy Medical Center

Cedar Rapids, Iowa, United States, 52403

Actively Recruiting

35

UI Health Care Mission Cancer and Blood - West Des Moines Clinic

Clive, Iowa, United States, 50325

Suspended

36

Mercy Medical Center - Des Moines

Des Moines, Iowa, United States, 50314

Actively Recruiting

37

UI Health Care Mission Cancer and Blood - Laurel Clinic

Des Moines, Iowa, United States, 50314

Suspended

38

Trinity Health Saint Joseph Mercy Hospital Ann Arbor

Ann Arbor, Michigan, United States, 48106

Actively Recruiting

39

Trinity Health IHA Medical Group Hematology Oncology - Brighton

Brighton, Michigan, United States, 48114

Actively Recruiting

40

Trinity Health Medical Center - Brighton

Brighton, Michigan, United States, 48114

Actively Recruiting

41

Trinity Health IHA Medical Group Hematology Oncology - Canton

Canton, Michigan, United States, 48188

Actively Recruiting

42

Trinity Health Medical Center - Canton

Canton, Michigan, United States, 48188

Actively Recruiting

43

Chelsea Hospital

Chelsea, Michigan, United States, 48118

Actively Recruiting

44

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

Chelsea, Michigan, United States, 48118

Actively Recruiting

45

Cancer Hematology Centers - Flint

Flint, Michigan, United States, 48503

Actively Recruiting

46

Genesee Hematology Oncology PC

Flint, Michigan, United States, 48503

Suspended

47

Genesys Hurley Cancer Institute

Flint, Michigan, United States, 48503

Actively Recruiting

48

Hurley Medical Center

Flint, Michigan, United States, 48503

Actively Recruiting

49

University of Michigan Health - Sparrow Lansing

Lansing, Michigan, United States, 48912

Actively Recruiting

50

Trinity Health Saint Mary Mercy Livonia Hospital

Livonia, Michigan, United States, 48154

Actively Recruiting

51

Trinity Health Saint Joseph Mercy Oakland Hospital

Pontiac, Michigan, United States, 48341

Actively Recruiting

52

Huron Gastroenterology PC

Ypsilanti, Michigan, United States, 48106

Actively Recruiting

53

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

Ypsilanti, Michigan, United States, 48197

Actively Recruiting

54

Essentia Health - Deer River Clinic

Deer River, Minnesota, United States, 56636

Actively Recruiting

55

Essentia Health Cancer Center

Duluth, Minnesota, United States, 55805

Actively Recruiting

56

Essentia Health Hibbing Clinic

Hibbing, Minnesota, United States, 55746

Actively Recruiting

57

Essentia Health Sandstone

Sandstone, Minnesota, United States, 55072

Actively Recruiting

58

Essentia Health Virginia Clinic

Virginia, Minnesota, United States, 55792

Actively Recruiting

59

University of Mississippi Medical Center

Jackson, Mississippi, United States, 39216

Actively Recruiting

60

Siteman Cancer Center at Saint Peters Hospital

City of Saint Peters, Missouri, United States, 63376

Actively Recruiting

61

Siteman Cancer Center at West County Hospital

Creve Coeur, Missouri, United States, 63141

Actively Recruiting

62

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Actively Recruiting

63

Siteman Cancer Center-South County

St Louis, Missouri, United States, 63129

Actively Recruiting

64

Siteman Cancer Center at Christian Hospital

St Louis, Missouri, United States, 63136

Actively Recruiting

65

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center

New York, New York, United States, 10032

Actively Recruiting

66

University of Rochester

Rochester, New York, United States, 14642

Actively Recruiting

67

Wilmot Cancer Institute at Webster

Webster, New York, United States, 14580

Actively Recruiting

68

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, United States, 73104

Actively Recruiting

69

Providence Newberg Medical Center

Newberg, Oregon, United States, 97132

Actively Recruiting

70

Providence Willamette Falls Medical Center

Oregon City, Oregon, United States, 97045

Actively Recruiting

71

Providence Portland Medical Center

Portland, Oregon, United States, 97213

Actively Recruiting

72

Providence Saint Vincent Medical Center

Portland, Oregon, United States, 97225

Actively Recruiting

73

Medical University of South Carolina

Charleston, South Carolina, United States, 29425

Actively Recruiting

74

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

75

Ben Taub General Hospital

Houston, Texas, United States, 77030

Actively Recruiting

76

University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States, 78229

Actively Recruiting

77

Huntsman Cancer Institute/University of Utah

Salt Lake City, Utah, United States, 84112

Actively Recruiting

78

VCU Massey Cancer Center at Stony Point

Richmond, Virginia, United States, 23235

Actively Recruiting

79

VCU Massey Comprehensive Cancer Center

Richmond, Virginia, United States, 23298

Actively Recruiting

80

ThedaCare Regional Cancer Center

Appleton, Wisconsin, United States, 54911

Actively Recruiting

81

Duluth Clinic Ashland

Ashland, Wisconsin, United States, 54806

Actively Recruiting

82

Aurora Cancer Care-Southern Lakes VLCC

Burlington, Wisconsin, United States, 53105

Actively Recruiting

83

Marshfield Medical Center-EC Cancer Center

Eau Claire, Wisconsin, United States, 54701

Actively Recruiting

84

Aurora Health Care Germantown Health Center

Germantown, Wisconsin, United States, 53022

Actively Recruiting

85

Aurora Cancer Care-Grafton

Grafton, Wisconsin, United States, 53024

Actively Recruiting

86

Aurora BayCare Medical Center

Green Bay, Wisconsin, United States, 54311

Actively Recruiting

87

Aurora Cancer Care-Kenosha South

Kenosha, Wisconsin, United States, 53142

Actively Recruiting

88

Gundersen Lutheran Medical Center

La Crosse, Wisconsin, United States, 54601

Actively Recruiting

89

Aurora Bay Area Medical Group-Marinette

Marinette, Wisconsin, United States, 54143

Actively Recruiting

90

Marshfield Medical Center-Marshfield

Marshfield, Wisconsin, United States, 54449

Actively Recruiting

91

Aurora Cancer Care-Milwaukee

Milwaukee, Wisconsin, United States, 53209

Actively Recruiting

92

Aurora Saint Luke's Medical Center

Milwaukee, Wisconsin, United States, 53215

Actively Recruiting

93

Aurora Sinai Medical Center

Milwaukee, Wisconsin, United States, 53233

Actively Recruiting

94

Marshfield Medical Center - Minocqua

Minocqua, Wisconsin, United States, 54548

Actively Recruiting

95

Vince Lombardi Cancer Clinic - Oshkosh

Oshkosh, Wisconsin, United States, 54904

Actively Recruiting

96

Aurora Cancer Care-Racine

Racine, Wisconsin, United States, 53406

Actively Recruiting

97

Marshfield Medical Center-Rice Lake

Rice Lake, Wisconsin, United States, 54868

Actively Recruiting

98

Vince Lombardi Cancer Clinic-Sheboygan

Sheboygan, Wisconsin, United States, 53081

Actively Recruiting

99

Marshfield Medical Center-River Region at Stevens Point

Stevens Point, Wisconsin, United States, 54482

Actively Recruiting

100

Aurora Medical Center in Summit

Summit, Wisconsin, United States, 53066

Actively Recruiting

101

Vince Lombardi Cancer Clinic-Two Rivers

Two Rivers, Wisconsin, United States, 54241

Actively Recruiting

102

Aurora Cancer Care-Milwaukee West

Wauwatosa, Wisconsin, United States, 53226

Actively Recruiting

103

Aurora West Allis Medical Center

West Allis, Wisconsin, United States, 53227

Actively Recruiting

104

Marshfield Medical Center - Weston

Weston, Wisconsin, United States, 54476

Actively Recruiting

Loading map...

Research Team

K

Katarina Gasic

CONTACT

C

Crystal Miwa

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

5

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment | DecenTrialz